Global Nebulizer Market, By Product Type (Ultrasonic Nebulizers, Pneumatic Nebulizer, Mesh Nebulizers) End Use (Hospitals & Clinics, Emergency Centre, Home Healthcare), Industry Trends and Forecast to 2029
Market Analysis and Insights
Chronic respiratory diseases are illnesses that affect the lungs' airways and other parts. Respiratory symptoms are among the most common reasons for visits to doctors and physicians in primary care settings. Asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, sleep apnea, and tuberculosis are some of the major preventable chronic respiratory disorders (principally, multi-drug resistant tuberculosis). Tobacco smoking is one of the primary causes of the global rise in respiratory diseases. Excessive pollution in metropolitan cities and industrial lands is another factor contributing to the increased prevalence of respiratory diseases. Furthermore, second-hand smoke exposure causes severe respiratory diseases.
Nebulizer market is expected to gain market growth at a potential rate of 7.5% in the forecast period of 2020 to 2029 and would reach an estimated value of 1.33 billion by the end of the forecast period. The growing prevalence of chronic respiratory diseases is fuelling the growth of the nebulizer market.
Market Definition
A nebulizer is a type of medical device that is used to convert a drug into a spray and deliver it directly to the lungs. This is mostly used to treat lung diseases such as asthma, cystic fibrosis, and COPD. The rise in the prevalence rate of chronic respiratory diseases is escalating the growth of nebulizers market.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Ultrasonic Nebulizers, Pneumatic Nebulizer, Mesh Nebulizers) End Use (Hospitals & Clinics, Emergency Centre, Home Healthcare),
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa
|
|
Market Players Covered
|
Adherium (US), AstraZeneca (U.K), Boehringer Ingelheim International GmbH (Germany), Cohero Health, Inc. (US), GSK Group of Companies (U.K), Teva Pharmaceutical Industries Limited (Israel), Vectura Group Ltd. (United Kingdom), Propeller Health (US), Novartis AG (Switzerland), OPKO Health Inc. (US), AptarGroup, Inc. (US), Sensirion AG (Switzerland)
|
Nebulizer Market Dynamics
Drivers
- Rise in the ageing population
The rises in the demand for home healthcare devices, as well as the ageing population, are expected to drive the growth of the nebulizers market during the forecast period.
- Increasing technological advancements
The nebulizers market is expected to grow further as a result of technological advancements. On the other hand, the decrease in the quantity of drugs used during nebulization is expected to boost the growth of the nebulizers market over the forecast period.
Opportunities
The growing demand for home healthcare devices will provide additional opportunities for the nebulizers market to grow in the coming years.
Restraints/Challenges
The decrease in the quantity of drugs used during nebulization is also expected to impede the growth of the nebulizers market over the forecast period. In the near future, the spraying technique may pose a new challenge to the growth of the nebulizers market.
This nebulizer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on nebulizer market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Nebulizer Market
The pandemic of COVID-19 is expected to have a significant impact on the market. Albuterol inhalers are being used more frequently in hospitals to help COVID-19 and suspected COVID-19 patients with respiratory issues. This is primarily due to the fact that respiratory viruses are the most common cause of asthma complications, and nebulizers can help provide relief. Furthermore, due to a variety of factors, including the gradual decline of immune function, older people are more vulnerable to respiratory diseases such as chronic obstructive pulmonary disease (COPD), sleep apnea, and the COVID-19.
Recent Developments
- PARI Pharma GmbH announced in March 2021 the approval of the LAMIRA Nebulizer System for the delivery of Insmed's drug product ARIKAYCE in Japan.
- AireHealth announced in December 2020 that its connected nebulizer had been cleared by the US Food and Drug Administration (FDA). The device is a portable, electronic vibrating mesh nebulizer designed to nebulize liquid medications for inhalation by patients both inside and outside the home.
- OMRON Healthcare announced the launch of its new compressor nebulizer, the OMRON NE C106, in India in July 2020.
Global Nebulizer Market Scope
The nebulizer market is segmented on the basis of product type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Tyoe
- Ultrasonic nebulizers
- Pneumatic nebulizer
- Mesh nebulizers
On the basis of product type, the nebulizers market is segmented into ultrasonic nebulizers, pneumatic nebulizer, mesh nebulizers.
End Use
- Hospitals & clinics
- Emergency centre
- Home healthcare
On the basis of end user, the nebulizers market is segmented into hospitals & clinics, emergency centre, home healthcare.
Nebulizer Market Regional Analysis/Insights
The nebulizer market is analysed and market size insights and trends are provided by country, product type and end user as referenced above.
The countries covered in the nebulizer market report U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the nebulizers market due to technological advancements and product launches. Furthermore, the rising prevalence of respiratory disorders will drive the region's nebulizers’ market growth during the forecast period. The Asia-Pacific nebulizers market is expected to grow significantly due to an ageing population and a greater emphasis on preventive care. Furthermore, the government's initiatives to support technological innovations, as well as an increase in the use of respiratory devices, such as postoperative rooms, delivery rooms, and care units, are expected to drive the growth of the nebulizers market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Nebulizer Market Share Analysis
The nebulizer market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to nebulizer market.
Some of the major players operating in the nebulizer market are Adherium (US), AstraZeneca (U.K), Boehringer Ingelheim International GmbH (Germany), Cohero Health, Inc. (US), GSK Group of Companies (U.K), Teva Pharmaceutical Industries Limited (Israel), Vectura Group Ltd. (United Kingdom), Propeller Health (US), Novartis AG (Switzerland), OPKO Health Inc. (US), AptarGroup, Inc. (US), Sensirion AG (Switzerland)
SKU-